Paratek Pharmaceuticals Inc

CITADEL ADVISORS LLC

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/14/2023

Shares

203,159

Value ($000)

380

Weight

0.0%

2019 Q4 - 2022 Q4 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/14/2023	380	0.0%	203,159	12/31/2022
2022 Q3	11/14/2022	108	0.0%	41,883	9/30/2022
2022 Q2	8/15/2022	193	0.0%	99,862	6/30/2022
2022 Q1	5/16/2022	330	0.0%	111,022	3/31/2022
2021 Q4	2/14/2022	762	0.0%	169,648	12/31/2021
2021 Q3	11/15/2021	133	0.0%	27,439	9/30/2021
2021 Q2	8/16/2021	187	0.0%	27,455	6/30/2021
2020 Q4	2/16/2021	303	0.0%	48,540	12/31/2020
2020 Q2	8/14/2020	186	0.0%	35,672	6/30/2020
2020 Q1	5/15/2020	91	0.0%	28,790	3/31/2020
2019 Q4	2/14/2020	338	0.0%	83,774	12/31/2019